The Pharmaceutical Excipients Report is Segmented by Product (Organic Chemicals and Inorganic Chemicals), Functionality (Fillers & Diluents, and More), Formulation (Oral Solid Dosage Forms, and More), Source (Plant-Based, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

FMI’s comprehensive reports on the pharmaceutical sector now see the addition of an updated study on the pharmaceutical excipient market. According to updated research, the market is set to hold a valuation of US$ 972.9 million in 2024. Thereafter, the market’s progress over the coming decade is suggested to be solid, with a CAGR of 5.1%. As such, the market’s value by 2034 is marked to jump to US$ 1,600.0 million.

Category-wise Outlook

Country-wise Analysis

Pharmaceutical Excipients Market to grow from USD 10.70 billion in 2024 to USD 20.22 billion by 2034 at 6.6% CAGR, driven by organic chemicals and advanced tablet formulations.

The global pharmaceutical excipients market is growing due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems.

In 2023, North America held 39 percent of the global pharmaceutical excipients market. This statistic shows the share of the global pharmaceutical excipients market by region.

Pharmaceutical Excipients Market valuation is estimated to USD 10.96 Bn in 2025 and is anticipated to grow to USD 19.29 Bn by 2032 with steady CAGR of 8.4% .

BCC Research Market Analyst says global market for pharmaceutical excipients was valued at $9.2 billion in 2023. It is expected to grow from $9.6 billion in 2024 to $12.3 billion by the end of 2029, at a CAGR of 5.1%.

According to global market forecasts, the pharmaceutical excipients market is expected to increase from around nine billion U.S. dollars in 2023 to some 18 billion U.S. dollars in 2032. This statistic shows the global market size of pharmaceutical excipients in 2023 and a forecast for 2032.

Access Market Research Intellect's Pharmaceutical Excipients Market Report for insights on a market worth USD 4.5 billion in 2024, expanding to USD 7.2 billion by 2033, driven by a CAGR of 6.5%.Learn about growth opportunities, disruptive technologies, and leading market participants.

Pharmaceutical Excipients Market is estimated to be USD 10.49 billion by 2030 with a CAGR of 5.3% during the forecast period

Snapshot img

Pharmaceutical Excipients Market Size 2025-2029

The pharmaceutical excipients market size is valued to increase USD 5.21 billion, at a CAGR of 7.7% from 2024 to 2029. Increasing demand for functional excipients will drive the pharmaceutical excipients market.

Major Market Trends & Insights

North America dominated the market and accounted for a 44% growth during the forecast period.
By Type - Organic segment was valued at USD 7.73 billion in 2023
By Product - Binders and fillers segment accounted for the largest market revenue share in 2023

Market Size & Forecast

Market Opportunities: USD 80.78 billion
Market Future Opportunities: USD 5.21 billion 
CAGR : 7.7%
North America: Largest market in 2023

Market Summary

The market encompasses a diverse range of inactive ingredients used in the formulation of pharmaceutical drugs. Core technologies and applications, such as wet granulation and direct compression, continue to evolve, driving the demand for advanced excipients. Service types or product categories, including functional excipients and binding agents, are in high demand due to their role in improving drug bioavailability and patient compliance. Regulatory compliance, particularly with stringent regulations like the FDA's Current Good Manufacturing Practice (CGMP), poses challenges for market participants.
Looking ahead, the forecast period presents opportunities for growth, with increasing demand for new excipients to develop easily consumable drugs. For instance, the adoption of hydroxypropyl methylcellulose (HPMC) as a tablet binder has surged by over 5% in recent years. Related markets such as the dietary supplements and nutraceuticals industries also contribute to the market's dynamic landscape.

What will be the Size of the Pharmaceutical Excipients Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Pharmaceutical Excipients Market Segmented and what are the key trends of market segmentation?

The pharmaceutical excipients industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Organic
  Inorganic


Product

  Binders and fillers
  Coating agents
  Disintegrants
  Others


Route Of Administration

  Oral excipients
  Topical excipients
  Parenteral excipients
  Others


Form Factor

  Solid
  Semi-solid
  Liquid


End-User

  Pharmaceutical Companies
  Contract Manufacturing Organizations
  Research Institutes


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Middle East and Africa

    Egypt
    KSA
    Oman
    UAE


  APAC

    China
    India
    Japan


  South America

    Argentina
    Brazil


  Rest of World (ROW)

By Type Insights

The organic segment is estimated to witness significant growth during the forecast period.

Pharmaceutical excipients play a crucial role in drug formulation, ensuring optimal efficacy and patient compliance. Organically derived excipients, including oleochemicals, carbohydrates, petrochemicals, proteins, and others, dominate the market. Oleochemical-based excipients, such as fatty alcohols, mineral stearates, and glycerin, account for a significant market share. Carbohydrate-based excipients, comprising sugars, sugar alcohols, artificial sweeteners, cellulose, starch, and petrochemicals, are essential components. Sugars like lactose, sucrose, and dextrose, sugar alcohols such as sorbitol and mannitol, artificial sweeteners, and various cellulose derivatives like microcrystalline cellulose, carboxymethyl cellulose (CMC), croscarmellose sodium, and cellulose esters are widely used. Starch types, including modified starch, dried starch, and converted starch, and petrochemicals like glycol, povidones, mineral hydrocarbons (petrolatum, mineral waxes, and mineral oils), and acrylic polymers, are also integral.

Biocompatibility testing is essential to ensure excipients do not adversely affect the patient. Emulsifiers and stabilizers, such as polysorbates, lecithin, and sodium lauryl sulfate, are vital for maintaining drug stability. Pharmacopeial standards and regulatory compliance are stringent, with regulatory bodies like the FDA and EMA setting guidelines. Degradation pathways, drug delivery systems, compression behavior, suspending agents, and pharmaceutical coatings are all critical aspects of the market.

The market for pharmaceutical excipients is expected to grow substantially, with a reported 15% increase in demand from the pharmaceutical industry. Furthermore, the market for pharmaceutical excipients in the biotechnology sector is projected to expand by 18%, driven by the rising demand for biologics and biosimilars. These trends re

Pharmaceutical Excipients Market was valued at $10.46 Billion in 2023, and is projected to $USD 17.66 Billion by 2032, at a CAGR of 6% from 2023 to 2032.

The pharmaceutical excipients market was valued at USD 11.50 Billion in 2024, driven by the growing demand for biopharmaceuticals and advancements in drug formulation technologies across the globe. The market is anticipated to grow at a CAGR of 6.50% during the forecast period of 2025-2034, with the values likely to reach USD 21.59 Billion by 2034.

The pharmaceutical excipients market, valued at $9.94 billion in 2025, is projected to experience robust growth, driven by a Compound Annual Growth Rate (CAGR) of 7.93% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases globally necessitates a higher demand for pharmaceuticals, consequently boosting the need for excipients crucial in drug formulation. Secondly, the ongoing innovation in drug delivery systems, such as targeted drug delivery and sustained-release formulations, is driving demand for specialized excipients with enhanced functionalities. Thirdly, the rising focus on improving drug stability, bioavailability, and patient compliance further fuels market growth. Major players like Air Liquide, BASF, and DuPont are significantly contributing to market expansion through continuous research and development, expanding product portfolios, and strategic partnerships. However, stringent regulatory approvals and potential fluctuations in raw material prices pose challenges to market growth. The market segmentation, while not explicitly provided, likely includes various types of excipients categorized by their function (binders, fillers, diluents, etc.) and application (oral, injectable, topical, etc.). Regional analysis would reveal variations in market share, likely with North America and Europe dominating initially due to established pharmaceutical industries and robust healthcare infrastructure. However, emerging markets in Asia-Pacific and Latin America are anticipated to show significant growth potential owing to expanding healthcare sectors and increasing pharmaceutical manufacturing activities. The forecast period (2025-2033) suggests continued market expansion, driven by the long-term trends of an aging population, rising healthcare expenditure, and technological advancements in the pharmaceutical industry. The historical period (2019-2024) likely showcased a similar, albeit perhaps slightly lower, growth trajectory, providing a solid foundation for the projected future growth. Recent developments include: October 2023: Clariant, a sustainability-focused specialty chemicals company, launched its portfolio of high-performing pharmaceutical ingredient solutions to support the evolution of safe and effective medicines. Also, Clariant Health Care expanded its range of functional excipients to solve active pharmaceutical ingredient (API) delivery & bioavailability challenges., September 2023: Roquette, a company focused on plant-based ingredients and a provider of pharmaceutical and nutraceutical excipients, launched three new excipient grades to its portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical ingredients.. Key drivers for this market are: Increasing Demand for Functionality Excipients, Recent Patents Expiries Driving the Demand for Pharmaceutical Excipients; Rapid Advancements in Nanotechnology. Potential restraints include: Increasing Demand for Functionality Excipients, Recent Patents Expiries Driving the Demand for Pharmaceutical Excipients; Rapid Advancements in Nanotechnology. Notable trends are: Binders Segment is Expected to Show a Significant Growth Over the Forecast Period.

The global Pharmaceutical Excipients Market size is expected to reach USD 10.43 Billion in 2032 registering a CAGR of 5.7%. Our report provides a comprehensive overview of the industry, including key players, market share, growth opportunities and more.

Check Market Research Intellect's Organic Pharmaceutical Excipients Market Report, pegged at USD 5.2 billion in 2024 and projected to reach USD 9.1 billion by 2033, advancing with a CAGR of 7.5% (2026-2033).Explore factors such as rising applications, technological shifts, and industry leaders.

The size of the Pharmaceutical Excipients Market was valued at USD 9.94 Million in 2023 and is projected to reach USD 16.96 Million by 2032, with an expected CAGR of 7.93% during the forecast period. Recent developments include: October 2023: Clariant, a sustainability-focused specialty chemicals company, launched its portfolio of high-performing pharmaceutical ingredient solutions to support the evolution of safe and effective medicines. Also, Clariant Health Care expanded its range of functional excipients to solve active pharmaceutical ingredient (API) delivery & bioavailability challenges., September 2023: Roquette, a company focused on plant-based ingredients and a provider of pharmaceutical and nutraceutical excipients, launched three new excipient grades to its portfolio of solutions for moisture-sensitive active pharmaceutical and nutraceutical ingredients.. Key drivers for this market are: Increasing Demand for Functionality Excipients, Recent Patents Expiries Driving the Demand for Pharmaceutical Excipients; Rapid Advancements in Nanotechnology. Potential restraints include: Lack of Proper Approval Process, Adverse Reactions of Excipients and Contamination in Formulations. Notable trends are: Binders Segment is Expected to Show a Significant Growth Over the Forecast Period.

In 2023, the global market for pharmaceutical excipients was expected to be around 7.2 billion U.S. dollars. In the course of the next decade, the market is expected to increase with a CAGR of 5.8 percent to roughly 12 billion dollars by 2032.

Pharma Excipient Market was valued at USD 6.93 billion in 2022 and is expected to reach USD 9.81 Billion in 2034 registering a CAGR of 5.6% during the forecast period.

According to the Cognitive Market Research Report, the pharmaceutical excipients Market size in 2024 was xx Million and is projected to have a compounded annual growth rate of xx% from 2024 to 2031.

The pharmaceutical excipients market is experiencing robust growth to expand significantly in the coming years. This has an increasing demand for generic drugs.
Innovations within the sector, notably the development of multifunctional and novel excipients, are enhancing drug formulation efficiency and functionality, thus driving market progression. 
However, high development costs and stringent regulatory landscapes present challenges to market expansion. Despite these hurdles, the market sees promising opportunities in the elevation of functional excipients and the growing inclination towards organic and inorganic chemical-based excipients for diverse pharmaceutical applications.
The future of excipients science and technology has changed and continues to change. Better progress has been made in such areas as harmonizing excipient pharmacopeial monographs and applying new analytical methods to characterize excipients better.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. 

Market Dynamics of the Pharmaceutical Excipients Market

Key Drivers of the Pharmaceutical Excipients Market

Natural and Biodegradable Excipients have great value in the pharmaceutical excipients market which boosts the market

Looking upon the natural and biodegradable pharmaceutical excipients, there is a remarkable shift towards natural and biodegradable excipients. Natural and biodegradable pharmaceutical excipients are eco-friendly. Pharmaceutical excipients were traditionally defined as inactive components crucial to guarantee the adequate quality, safety, and efficacy of APIs, which are derived from different sources, such as biological, mineral, vegetal, and chemical synthesis-based. For thousands of years, nature has been a source of vital ingredients for treatments, which have been used not only as complex mixtures with a variable composition but also as pure, quantifiable, and chemically known compounds. Natural raw materials as excipients for topical green formulations • For instance the idea of green chemistry was initially considered as a response to the Federal Pollution Prevention Act of 1990 in the United States and its first aim was to minimize waste and toxicity, maximize efficiency, and use renewable resources whenever possible. This concept has spread through all areas, and many innovative businesses introduced the term green products, referring to products created with the aim of a sustainable, environmentally friendly industry that protects human health. (Source:https://www.epa.gov/greenchemistry/basics-green-chemistry)

Customized Excipient Solutions has the best alternative for effective drug formulation for better efficiency of medication

Pharmaceutical companies are increasing their partnership with excipient manufacturers to develop custom-made solutions for effective drug formulations. This cooperation allows for better formulation enhancement and improved drug performance. Several existing excipients lack some of the desirable properties required in some formulations, viz., soluble tablets, in which an ideal lubricant should be water soluble with effectiveness similar to that of magnesium stearate. In addition to custom pharmaceutical excipients development, Formulationbio also provides other services like pre-formulation, formulation, and drug analysis services for pharmaceutical companies. Additionally, industry collaborations and partnerships for customized excipients are likely to help the market grow shortly • For instance In August 2023, EPR reported on the European Medicines Agency (EMA)’s regulatory perspective on nitrosamine mitigation strategies. The publication highlighted that while nitrite concentration in excipients is a “key risk factor in nitrosamine drug substance-related impurities (NDSRI) formation, the...